Nursing Skill and Responsibility in Administration of Injection Actilyse

Mayur B. Wanjari *

Department of Community Health Nursing, Smt. Radhikabai Meghe Memorial College of Nursing, Datta Meghe Institute of Medical Sciences, Sawangi (M), Wardha, Maharashtra, India.

Deeplata Mendhe

Department of Community Health Nursing, Smt. Radhikabai Meghe Memorial College of Nursing, Datta Meghe Institute of Medical Sciences, Sawangi (M), Wardha, Maharashtra, India.

Pratibha Wankhede

Department of Community Health Nursing, Smt. Radhikabai Meghe Memorial College of Nursing, Datta Meghe Institute of Medical Sciences, Sawangi (M), Wardha, Maharashtra, India.

*Author to whom correspondence should be addressed.


Abstract

Actilyse can break blood clots that form in the heart, blood arteries, or lungs during a heart attack. This medication is also given to stroke patients to improve recovery and reduce the likelihood of impairment. Recombinant DNA technology was used to create Activase, a tissue plasminogen activator. It is a sterile, purified glycoprotein of 527 amino acids. It is made by combining complementary DNA (cDNA) from a human melanoma cell line with the natural human tissue-type plasminogen activator. After reconstitution with Sterile Water for Injection, USP, Activase is a sterile, white to off-white lyophilized powder for intravenous injection.

Keywords: Actilyse, stroke, activase, glycoprotein, lyophilized powder


How to Cite

Wanjari, M. B., Mendhe, D. and Wankhede, P. (2021) “Nursing Skill and Responsibility in Administration of Injection Actilyse”, Journal of Pharmaceutical Research International, 33(57B), pp. 151–155. doi: 10.9734/jpri/2021/v33i57B34039.